BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
91.22
+1.22 (1.36%)
At close: Jun 26, 2026, 4:00 PM EDT
90.53
-0.69 (-0.76%)
After-hours: Jun 26, 2026, 7:43 PM EDT
BioNTech SE Employees
BioNTech SE had 7,807 employees as of December 31, 2025. The number of employees increased by 1,035 or 15.28% compared to the previous year.
Employees
7,807
Change (1Y)
1,035
Growth (1Y)
15.28%
Revenue / Employee
$414,296
Profits / Employee
-$184,935
Market Cap
23.07B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7,807 | 1,035 | 15.28% |
| Dec 31, 2024 | 6,772 | 639 | 10.42% |
| Dec 31, 2023 | 6,133 | 1,603 | 35.39% |
| Dec 31, 2022 | 4,530 | 1,448 | 46.98% |
| Dec 31, 2021 | 3,082 | 1,141 | 58.78% |
| Dec 31, 2020 | 1,941 | 631 | 48.17% |
| Dec 31, 2019 | 1,310 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| BeOne Medicines AG | 12,000 |
| Moderna | 4,700 |
| Genmab | 3,088 |
| Jazz Pharmaceuticals | 2,890 |
| Incyte | 2,844 |
| Insmed | 1,664 |
| Ascendis Pharma | 1,189 |
| Revolution Medicines | 883 |
BNTX News
- 10 days ago - Moderna interested in Germany production, sees opportunity in BioNTech closures, says CEO - Reuters
- 27 days ago - BioNTech, Bristol announce interim Phase 2 data from Rosetta Lung-02 trial - TheFly
- 4 weeks ago - Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial - GlobeNewsWire
- 4 weeks ago - This Biotech's Cancer Portfolio Could End Its Rough Patch - Barrons
- 4 weeks ago - BioNTech upgraded to Buy from Neutral at UBS - TheFly
- 5 weeks ago - BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting - GlobeNewsWire
- 5 weeks ago - Bernstein starts BioNTech at Market Perform, sees high registration risk - TheFly
- 5 weeks ago - BioNTech initiated with a Market Perform at Bernstein - TheFly